Jones J G, Carvalho R A, Franco B, Sherry A D, Malloy C R
Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA.
Anal Biochem. 1998 Oct 1;263(1):39-45. doi: 10.1006/abio.1998.2796.
13C and 1H NMR spectroscopy of plasma glucose was used to resolve the isotopomer contributions from tracer levels of [1,6-13C2]glucose, a novel tracer of glucose carbon skeleton turnover, and [U-13C]propionate, a tracer of hepatic citric acid cycle metabolism. This allowed simultaneous measurements of hepatic glucose production and citric acid cycle fluxes from the NMR analysis of a single plasma glucose sample in fasted animals. Glucose carbon skeleton turnover, as reported by the dilution of [1,6-13C2]glucose, was 56 +/- 2 micromol/kg/min in the presence of labeling from [U-13C]propionate and 53 +/- 4 micromol/kg/min in its absence. Therefore, as expected, the labeling contributions from [U-13C]propionate metabolism did not have a significant effect on the measurement of glucose turnover. For the group infused with both tracers, citric acid cycle flux estimates from the analysis of glucose C2 isotopomer ratios were consistent with those from our recent experiments where only [U-13C]propionate was infused, verifying that the presence of [1,6-13C2]glucose did not interfere with these measurements. This integrated analysis of hepatic glucose output and citric acid cycle fluxes from plasma glucose isotopomers yielded a noninvasive estimate of hepatic citrate synthase flux of 74 +/- 12 micromol/kg/min for 24-h fasted rats.
利用血浆葡萄糖的13C和1H核磁共振波谱来解析[1,6-13C2]葡萄糖(一种新型的葡萄糖碳骨架周转示踪剂)和[U-13C]丙酸盐(一种肝柠檬酸循环代谢示踪剂)示踪水平的同位素异构体贡献。这使得能够通过对禁食动物单个血浆葡萄糖样本的核磁共振分析同时测量肝葡萄糖生成和柠檬酸循环通量。如[1,6-13C2]葡萄糖稀释所报告的,在存在[U-13C]丙酸盐标记时,葡萄糖碳骨架周转为56±2微摩尔/千克/分钟,在不存在[U-13C]丙酸盐标记时为53±4微摩尔/千克/分钟。因此,正如预期的那样,[U-13C]丙酸盐代谢的标记贡献对葡萄糖周转的测量没有显著影响。对于同时注入两种示踪剂的组,通过葡萄糖C2同位素异构体比率分析得出的柠檬酸循环通量估计值与我们最近仅注入[U-13C]丙酸盐的实验结果一致,证实了[1,6-13C2]葡萄糖的存在不会干扰这些测量。这种对血浆葡萄糖同位素异构体的肝葡萄糖输出和柠檬酸循环通量的综合分析得出,24小时禁食大鼠的肝柠檬酸合酶通量的无创估计值为74±12微摩尔/千克/分钟。